Pharvaris N.V.
$29.45+1.73%(+$0.50)
TickerSpark Score
54/100
53
Valuation
20
Profitability
15
Growth
84
Health
100
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PHVS research report →
52-Week Range78% of range
Low $15.46
Current $29.45
High $33.33
Companypharvaris.com
Pharvaris N. V. , a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases.
- CEO
- Berndt Axel Edvard Modig
- IPO
- 2021
- Employees
- 108
- HQ
- Leiden, NL
Price Chart
+70.72% · this period
Valuation
- Market Cap
- $1.93B
- P/E
- -9.77
- P/S
- 0.00
- P/B
- 6.99
- EV/EBITDA
- -8.30
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -67.38%
- ROIC
- -72.74%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-175,699,397 · -30.90%
- EPS
- $-2.97 · -19.76%
- Op Income
- $-169,822,932
- FCF YoY
- -13.73%
Performance & Tape
- 52W High
- $33.33
- 52W Low
- $15.46
- 50D MA
- $28.35
- 200D MA
- $25.53
- Beta
- -2.33
- Avg Volume
- 258.61K
Get TickerSpark's AI analysis on PHVS
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 15, 26 | Glassman Robert | other | 5,333 |
| May 15, 26 | Glassman Robert | sell | 5,333 |
| May 15, 26 | Glassman Robert | sell | 4,667 |
| May 15, 26 | Glassman Robert | other | 5,333 |
| May 15, 26 | Abele Stefan Andreas | sell | 8,748 |
| May 15, 26 | Souverijns Wim | sell | 10,000 |
| May 11, 26 | Lu Peng | other | 109 |
| May 12, 26 | Lu Peng | other | 117 |
| May 1, 26 | Lu Peng | other | 14,023 |
| May 1, 26 | Lu Peng | other | 143 |
Our PHVS Coverage
We haven't published any research on PHVS yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate PHVS Report →